Clinical Trials Logo

Clinical Trial Summary

Non-Significant Risk Clinical Study Clinical Investigational Use Only for the purposes of collecting electromagnetic tracking data to validate the use of the device in a clinical setting.


Clinical Trial Description

The EMT Feasibility Study is a prospective, multi-center, feasibility study designed to demonstrate the feasibility of EMT solution in conjunction with the AcQMap 2.1 System's existing capabilities. The objective of the study is to demonstrate the ability of the AcQMap 2.1 System to support EMT in conjunction with the existing impedance localization capabilities. The new EMT technology is expected to continuously provide fully synchronized and similar localization information to the impedance-based localization information associated with the location of the catheter's magnetic sensor position. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05181878
Study type Observational
Source Acutus Medical
Contact Craig Dull, BS
Phone 442-232-6080
Email [email protected]
Status Recruiting
Phase
Start date December 29, 2021
Completion date April 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT03593486 - Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation N/A
Terminated NCT01546207 - Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia N/A
Not yet recruiting NCT04780438 - Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. Early Phase 1
Recruiting NCT03695484 - Registry Evaluating AF Ablation Techniques
Recruiting NCT04678258 - Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation N/A
Active, not recruiting NCT01630031 - Contact Force Sensing and Pulmonary Vein Isolation N/A
Completed NCT04896424 - Vagal Response and Cardiac Autonomic Modulation. Insides From Cryoballoon Ablation N/A
Recruiting NCT04906720 - Post-Ablation Pericarditis Reduction Study Phase 2
Completed NCT03140631 - Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation Phase 4
Active, not recruiting NCT03514693 - Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation N/A
Recruiting NCT03832959 - Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study. N/A
Recruiting NCT04405258 - Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial Phase 4
Completed NCT03340922 - MANual vs. automatIC Local Activation Time Annotation for Guiding Premature Ventricular Complex Ablation Phase 4
Not yet recruiting NCT04897204 - Left Atrial Appendage Electrical Isolation in Persistent Atrial Fibrillation N/A
Completed NCT03226847 - Pulmonary Vein Isolation in Athletes N/A
Recruiting NCT03729232 - Japanese Catheter Ablation Registry
Recruiting NCT04521790 - Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
Completed NCT00873067 - Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation Phase 3
Terminated NCT01144858 - Clinical Value of Left Atrial Appendage Flow for Prediction of Successful Catheter Ablation for Persistent Atrial Fibrillation N/A
Completed NCT03635034 - Bladder Catheters During Ablation Procedures N/A